M. Jo

发表

Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors.

S. Vandenberg, N. D. Staudt, M. Jo, 2013, Cancer research.

AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer

J. Nemunaitis, R. Kurzrock, M. Jo, 2015, Science Translational Medicine.

Dynamic Assembly of the Urokinase-type Plasminogen Activator Signaling Receptor Complex Determines the Mitogenic Activity of Urokinase-type Plasminogen Activator*

M. Jo, S. L. Gonias, S. Parsons, 2005, Journal of Biological Chemistry.

uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells

M. Jo, S. L. Gonias, V. Montel, 2007, The Journal of cell biology.

A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.

M. Jo, T. Nakajima, M. Moriguchi, 2006, Journal of hepatology.

oligonucleotide in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

J. Nemunaitis, R. Kurzrock, M. Jo, 2018 .

457 Preclinical pharmacology of AZD5312, a generation 2.5 antisense oligonucletotide targeting the androgen receptor with differentiated activity from enzalutamide

M. Jo, B. Davies, D. Blakey, 2014 .

Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.

M. Jo, S. L. Gonias, W. Mars, 2005, The Biochemical journal.

The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.

M. Jo, S. L. Gonias, V. Montel, 2009, The American journal of pathology.

Partial Hepatectomy Induced Long Noncoding RNA Inhibits Hepatocyte Proliferation during Liver Regeneration

Christopher E. Hart, S. Freier, M. Sabripour, 2015, PloS one.

uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages.

M. Jo, Jing-jing Hu, S. L. Gonias, 2014, The American journal of pathology.

Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells*

D. Stolz, G. Michalopoulos, S. Strom, 2000, The Journal of Biological Chemistry.

Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling*

M. Jo, S. L. Gonias, V. Montel, 2009, The Journal of Biological Chemistry.

Dynamic Phosphorylation of Tyrosine 665 in Pseudopodium-enriched Atypical Kinase 1 (PEAK1) Is Essential for the Regulation of Cell Migration and Focal Adhesion Turnover*

M. Jo, Jeanne M. Bristow, S. L. Gonias, 2012, The Journal of Biological Chemistry.

Modifications of the hepatocyte growth factor/c‐met pathway by constitutive expression of transforming growth factor‐α in rat liver epithelial cells

D. Stolz, G. Michalopoulos, S. Strom, 1997, Molecular carcinogenesis.

Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.

M. Jo, S. L. Gonias, R. Klemke, 2010, Cancer research.

Epidermal Growth Factor Receptor-dependent and -independent Cell-signaling Pathways Originating from the Urokinase Receptor*

M. Jo, S. L. Gonias, K. Thomas, 2003, The Journal of Biological Chemistry.

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

J. Nemunaitis, R. Kurzrock, M. Jo, 2018, Journal of Immunotherapy for Cancer.

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

S. Strom, M. Jo, D. Seol, 2000, Nature Medicine.

Soluble Urokinase-type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-independent Effects on Cell Signaling*

M. Jo, Lihua Wu, K. Thomas, 2003, Journal of Biological Chemistry.

Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell Migration*

M. Jo, A. Somlyo, A. Somlyo, 2002, The Journal of Biological Chemistry.

Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells

S. Vandenberg, W. Cavenee, F. Furnari, 2011, Proceedings of the National Academy of Sciences.

A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen.

M. Jo, B. Eastman, S. Takimoto, 2012, Cellular signalling.

Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells.

M. Jo, D. Webb, Z. Ma, 2001, Journal of cell science.

Low Density Lipoprotein Receptor-related Protein (LRP1) Regulates Rac1 and RhoA Reciprocally to Control Schwann Cell Adhesion and Migration*

M. Jo, W. Campana, E. Mantuano, 2010, The Journal of Biological Chemistry.

Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models

M. Jo, Tianyuan Zhou, Youngsoo Kim, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Unraveling pathologies underlying chromosomal instability in cancers

M. Jo, T. Hirota, Y. Kusano, 2021, Cancer science.

Erythropoietin Promotes MCF-7 Breast Cancer Cell Migration by an ERK/Mitogen-activated Protein Kinase-dependent Pathway and Is Primarily Responsible for the Increase in Migration Observed in Hypoxia*

M. Jo, R. D. Lester, W. Campana, 2005, Journal of Biological Chemistry.

Abstract 4359: Characterization of GalNAc-conjugated generation 2.5 ASOs in DEN and DEN/CCL4-induced HCC tumors

M. Jo, Tianyuan Zhou, Youngsoo Kim, 2015 .